Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial.
By L. Hajjar, Jean-Louis Vincent, F. Galas, R. Nakamura, Carolina M. P. D. C. Silva, M. Santos, J. Fukushima, R. Kalil Filho, D. B. Sierra, Neuza H M Lopes and 10 more. Journal of the American Medical Association (JAMA), 2010
937 citations recorded by the source corpus.
Subfields: Biochemistry, Critical Care and Intensive Care Medicine, Hematology
View Paper: https://www.semanticscholar.org/paper/2a03a3c1330902bbff5ac72c9f7a940073a96f5f
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Critical Care and Intensive Care Medicine
In Hematology
Citations in the corpus
- The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition (2016, background): “consistently found that restrictive transfusion strategies (haemoglobin thresholds between 16 7 – 9 g/dL) are as safe as, or safer than, liberal strategies (thresholds ≥9 g/dL) [260-263], 17 with the possible exception of patients following cardiac surgery [264] or with acute coronary 18 syndrome.”
- Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012 (2013, background): “36), Although less applicable to septic patients, results of a randomized trial in patients undergoing cardiac surgery with cardiopulmonary bypass support a restrictive transfusion strategy using a threshold hematocrit of \24 % (hemoglobin & 8 g/dL) as equivalent to a transfusion threshold of hemato”